Braun Stacey Associates Inc. Decreases Holdings in Welltower Inc. $WELL

Braun Stacey Associates Inc. decreased its holdings in Welltower Inc. (NYSE:WELL) by 2.3% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 216,915 shares of the real estate investment trust’s stock after selling 5,158 shares during the period. Welltower makes up about 1.4% of Braun Stacey Associates Inc.’s holdings, making the stock its 18th biggest holding. Braun Stacey Associates Inc.’s holdings in Welltower were worth $49,233,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. grew its stake in shares of Welltower by 5.5% during the second quarter. BlackRock Inc. now owns 78,049,214 shares of the real estate investment trust’s stock valued at $17,714,830,000 after buying an additional 4,045,458 shares during the last quarter. Capital International Investors boosted its holdings in Welltower by 2.0% during the 4th quarter. Capital International Investors now owns 47,431,769 shares of the real estate investment trust’s stock valued at $8,805,411,000 after acquiring an additional 915,514 shares during the period. State Street Corp grew its position in Welltower by 1.2% during the 4th quarter. State Street Corp now owns 41,760,328 shares of the real estate investment trust’s stock worth $7,751,134,000 after acquiring an additional 506,374 shares during the last quarter. Norges Bank purchased a new position in Welltower in the 4th quarter worth approximately $5,466,264,000. Finally, Bank of America Corp DE lifted its position in Welltower by 6.6% in the first quarter. Bank of America Corp DE now owns 21,750,501 shares of the real estate investment trust’s stock valued at $4,300,291,000 after purchasing an additional 1,347,243 shares during the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Welltower Price Performance

Shares of WELL stock opened at $237.51 on Friday. Welltower Inc. has a twelve month low of $163.75 and a twelve month high of $255.20. The stock has a market cap of $171.18 billion, a price-to-earnings ratio of 108.95, a PEG ratio of 1.15 and a beta of 0.76. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.37. The business’s fifty day moving average is $235.54 and its 200 day moving average is $217.59.

Welltower (NYSE:WELL) last released its earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.05). The business had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.40 billion. Welltower had a return on equity of 3.56% and a net margin of 12.15%.The firm’s quarterly revenue was up 39.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.28 earnings per share. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Research analysts expect that Welltower Inc. will post 6.43 EPS for the current fiscal year.

Welltower Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Wednesday, August 12th were issued a $0.85 dividend. This represents a $3.40 dividend on an annualized basis and a yield of 1.4%. This is a boost from Welltower’s previous quarterly dividend of $0.74. The ex-dividend date was Wednesday, August 12th. Welltower’s dividend payout ratio is currently 155.96%.

Insiders Place Their Bets

In other Welltower news, Director Andrew Gundlach bought 5,000 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was acquired at an average price of $239.47 per share, with a total value of $1,197,350.00. Following the completion of the purchase, the director owned 25,000 shares of the company’s stock, valued at approximately $5,986,750. This trade represents a 25.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. UBS Group increased their price objective on Welltower from $249.00 to $271.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Jefferies Financial Group upped their price target on shares of Welltower from $237.00 to $248.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Cantor Fitzgerald increased their price target on shares of Welltower from $235.00 to $260.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. BMO Capital Markets reissued an “outperform” rating and issued a $245.00 price target on shares of Welltower in a report on Monday, May 4th. Finally, KeyCorp boosted their price objective on shares of Welltower from $240.00 to $275.00 and gave the company an “overweight” rating in a research report on Tuesday, August 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Welltower presently has a consensus rating of “Moderate Buy” and a consensus target price of $246.11.

About Welltower

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.